Cases started on MDR-TB treatment in Algeria

Algeria: Cases started on MDR-TB treatment was 9 in 2023. ◆ Volatile

Latest (2023)
9
World rank
123rd
of 193 countries
All-time high
94
in 2015
All-time low
0
in 2022
Years of data
10
2009–2023

Cases started on MDR-TB treatment in Algeria, 2009–2023

0204060801002009201620232009: 932010: 562014: 562015: 942016: 752017: 532018: 532020: 542022: 02023: 9

Source: World Health Organization, Global Health Observatory.

Analysis

Algeria recorded 9 for cases started on mdr-tb treatment in 2023.

The figure is down 83.9% over ten years.

Over the whole period, cases started on mdr-tb treatment in Algeria peaked at 94 in 2015 and was at its lowest, 0, in 2022.

Algeria ranks 123rd of 193 countries on this measure, in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Averages by decade

DecadeAverage LowestHighest Years
2000s 93 93 93 1
2010s 64.5 53 94 6
2020s 21 0 54 3

Countries ranked near Algeria

  1. 122 Macao 10 compare
  2. 123 Qatar 9 compare
  3. 123 Cuba 9 compare
  4. 123 Bulgaria 9 compare
  5. 123 Cape Verde 9 compare
  6. 123 Guyana 9 compare
  7. 123 East Timor 9 compare
  8. 123 Greece 9 compare

See the full ranking of 205 places →

More health data for Algeria

All data for Algeria →

Frequently asked questions

What is cases started on mdr-tb treatment in Algeria?
Cases started on mdr-tb treatment in Algeria was 9 in 2023, according to World Health Organization, Global Health Observatory.
What is the highest cases started on mdr-tb treatment recorded in Algeria?
The highest recorded value was 94 in 2015.
What is the lowest cases started on mdr-tb treatment recorded in Algeria?
The lowest recorded value was 0 in 2022.
How does Algeria rank for cases started on mdr-tb treatment?
Algeria ranks 123rd out of 193 countries with data for 2023.
Is cases started on mdr-tb treatment rising or falling in Algeria?
Over the last ten years it is down 83.9%. The long-run trend across the full record is volatile.
Where does this Algeria data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Cases started on MDR-TB treatment. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

About this data

Indicator
Cases started on MDR-TB treatment
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
205 places, 3,209 data points, 2005–2024
Last refreshed